Notch Signaling Promotes Development of Allergic Rhinitis by Suppressing Foxp3 Expression and Treg Cell...

Area of Science:

• Immunology
• Molecular Biology

Background:

• The Notch signaling pathway is crucial for immune regulation, but its role in allergic rhinitis (AR) is not well understood.
• Investigating Notch signaling's involvement in AR pathogenesis is essential for developing targeted therapies.

Purpose of the Study:

• To elucidate the role of Notch signaling in the development of allergic rhinitis (AR).
• To examine how Notch signaling influences the function of Foxp3+ regulatory T cells (Tregs).

Main Methods:

• Serum analysis of Notch1, Jagged1, and DLL1 in AR patients versus controls.
• Murine models of AR treated with Notch inhibitors or dexamethasone.
• Assessment of allergic symptoms, IgE levels, Treg cell proportions, and cytokine profiles.

Main Results:

• Elevated Notch1 and Jagged1 expression in AR patients, correlating with disease severity and IgE levels.
• In AR mice, increased Notch signaling markers (Notch1, Jagged1, NICD) were associated with decreased Foxp3+ Treg cells.
• Notch inhibition in AR mice reduced allergic symptoms and IgE, while increasing Foxp3+ Tregs and rebalancing Th1/Th2 immune responses.

Conclusions:

• Notch signaling actively suppresses Foxp3 expression and Treg cell differentiation, thereby promoting AR.
• Targeting Notch signaling presents a promising therapeutic strategy for managing allergic rhinitis.